骨髓
T细胞受体
癌症研究
免疫学
遗传增强
T细胞
白血病
受体
持久性(不连续性)
生物
医学
基因
内科学
免疫系统
遗传学
工程类
岩土工程
作者
Isao Tawara,Shinichi Kageyama,Yoshihiro Miyahara,Hiroshi Fujiwara,Tetsuya Nishida,Yoshiki Akatsuka,Hiroaki Ikeda,Kazushi Tanimoto,Seitaro Terakura,Makoto Murata,Yoko Inaguma,Masahiro Masuya,Naoki Inoue,Tomohide Kidokoro,Sachiko Okamoto,Daisuke Tomura,Hideto Chono,Ikuei Nukaya,Junichi Mineno,Tomoki Naoe
出处
期刊:Blood
[American Society of Hematology]
日期:2017-08-31
卷期号:130 (18): 1985-1994
被引量:161
标识
DOI:10.1182/blood-2017-06-791202
摘要
Key Points WT1-specific TCR-redirected T-cell therapy for AML and MDS is safe, and the T cells persisted in vivo and trafficked to bone marrow. Transient decreases of leukemic cell in bone marrow were shown.
科研通智能强力驱动
Strongly Powered by AbleSci AI